Determined to turn the corner
Madrid – The Spanish Minister of Innovation and Science Cristina Garmendia has responded to reports about Roche’s delivery stop in Greece and pessimistic expectations for Spain. In September, she stressed that the atmosphere was “calm”, and that there would be “no problems” supplying Spanish hospitals and pharmacies with necessary drugs and supplies.
Alexander Klauser, a spokesman for the Swiss pharmaceutical giant, said the situation in Spain is difficult, but it is “not the same as it is in Greece.” By June of 2011, Spain’s health authorities had amassed a debt of €5.4bn, according to industry association Farmindustria.
In tough economic times, “Spain is taking the right steps forward,” the Science Minister said at the end of September. Soon after, researchers and companies signed a charter for an Alliance for Research and Innovation in Health (ALINNSA) that is being promoted by her Ministry. Its long-term stated aims are to integrate stakeholders in the field of biomedicine to help foster innovation and develop a national strategy for biomedical research.